Monday 29 April 2024
Internal Reference Number: FOI_6536
Date Request Received: 01/04/2022 00:00:00
Date Request Replied To: 20/04/2022 00:00:00
This response was sent via: By Email
Request Summary: immune thrombocytopenia (ITP)
Request Category: Private Individuals
| Question Number 1: How many patients has your trust treated (for any disease) in the last 6 months (or the latest 6 months data you have available) with the following treatments: • Revolade (eltrombopag) • Nplate (romiplostim) • Doptelet (avatrombopag) • Tavlesse (fostamatinib) | |
| Answer To Question 1: • Revolade (eltrombopag) 7 • Nplate (romiplostim) 8 • Doptelet (avatrombopag) 0 • Tavlesse (fostamatinib) 0 | |
| Question Number 2: In the last 6 months (or the latest 6 months data you have available), how many patients has your trust treated for immune thrombocytopenia (ITP)? | |
| Answer To Question 2: Less than 5 patients were treated at the trust for Immune Thrombocytopenia | |
| Question Number 3: Of the patients treated for immune thrombocytopenia (ITP) in the last 6 months (or the latest 6 months data you have available), how many were treated with: rituximab mycophenolate mofetil surgery (splenectomy) | |
| Answer To Question 3: This information is not recorded. | |
| Question Number 4: Does your trust participate in any ongoing clinical trials for immune thrombocytopenia (ITP)? If so, can you please provide the name of each trial along with the number of patients taking part? | |
| Answer To Question 4: No. The Trust does not participate in any clinical trials for ITP | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
